RecruitingNCT06544980
Measuring Upper Airway Cross Sectional Areas During Residual Neuromuscular Blockade and After Reserval
Sponsor
Tamas Vegh, MD
Enrollment
20 participants
Start Date
Jan 2, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
In our study, the investigators sought to answer the question of how the retroglossal pharyngeal areas measured after extubation of patients compare to baseline (before muscle relaxation) values. The investigators also investigated how these areas change as a function of TOF ratios measured at extubation, thus looking for a correlation between residual muscle relaxant effect and airway area.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria7
- Age: 18-65 years;
- ASA 1-3;
- BMI 18.5-25 (normal body weight);
- men/women in equal proportion;
- duration of surgeries at least ≥ 30 minutes;
- intervention requiring intratracheal intubation;
- patients are in a supine position.
Exclusion Criteria8
- diseases affecting neuromuscular function (myopathies, severe liver and kidney failure);
- drugs affecting neuromuscular function (magnesium, aminoglycosides);
- difficult airway, expected difficult intubation;
- pregnancy (pregnancy test for women of childbearing age to rule out pregnancy we finish);
- breastfeeding;
- acute surgery;
- COPD
- glaucoma
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06544980